成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Toggle Nav
Close
  • Menu
  • Setting

Plerixafor 8HCl (AMD3100 8HCl)

Catalog No.
B1465
CXCR4 antagonist
Grouped product items
SizePriceStock Qty
25mg
$105.00
In stock
50mg
$188.00
In stock
100mg
$366.00
In stock
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Plerixafor 8HCl (AMD3100 8HCl) is a potent and selective antagonist of CXCL12-mediated chemotaxis and G-protein coupled chemokine receptor (CXCR4) with IC50 values of 5.7 and 44 nM, respectively [1]. Plerixafor 8HCl has shown a high selectivity for CXCR4 compared other chemokine receptors including LTB4 CCR1, CCR2b, CCR4, CCR5, CCR7, CXCR3, etc [2].

Plerixafor 8HCl showed to inhibit I-SDF-1 ligand binding to CCRF–CEM T-lymphoblastoid cells which express CXCR4. Plerixafor 8HCl has shown to block CXCR4 activation, SDF-1 mediated calcium flux and SDF-1 mediated chemotaxis with IC50 values of 27.3, 572 and 51 nM, respectively [2].

References:
[1] Zabel BA1,?Wang Y,?Lewén S,?Berahovich RD,?Penfold ME,?Zhang P,?Powers J,?Summers BC,?Miao Z,?Zhao B,?Jalili A,?Janowska-Wieczorek A,?Jaen JC,?Schall TJ. Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands. J Immunol.?2009 Sep 1;183(5):3204-11. doi: 10.4049/jimmunol.0900269. Epub 2009 Jul 29.
[2] Fricker SP1,?Anastassov V,?Cox J,?Darkes MC,?Grujic O,?Idzan SR,?Labrecque J,?Lau G,?Mosi RM,?Nelson KL,?Qin L,?Santucci Z,?Wong RS. Characterization?of the?molecular?pharmacology?of?AMD3100: a?specific?antagonist?of the?G-protein?coupledchemokine?receptor,?CXCR4. Biochem Pharmacol.?2006 Aug 28;72(5):588-96.

Chemical Properties

Physical AppearanceA solid
StorageStore at -20°C
M.Wt794.47
Cas No.155148-31-5
FormulaC28H62Cl8N8
Solubility≥155.4 mg/mL in H2O; insoluble in DMSO; insoluble in EtOH
Chemical Name1-[[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane;octahydrochloride
SDFDownload SDF
Canonical SMILESC1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3.Cl.Cl.Cl.Cl.Cl.Cl.Cl.Cl
Shipping ConditionSmall Molecules with Blue Ice, Modified Nucleotides with Dry Ice.
General tips We do not recommend long-term storage for the solution, please use it up soon.

Protocol

Cell experiment [1]:

Cell lines

Bone marrow mononuclear cells (BMMCs)

Preparation method

Limited solubility. General tips for obtaining a higher concentration: Please warm the tube at 37 ℃ for 10 minutes and/or shake it in the ultrasonic bath for a while. Stock solution can be stored below -20℃ for several months.

Reacting condition

10 μM

Applications

In BMMCs, AMD3100 neutralizes the osteoclast formation promoted by SDF-1α. AMD3100 could also diminish the expression of osteoclast-specific proteins elevated by SDF-1α.
Animal experiment [2]:

Animal models

8-10 week-old specified pathogen-free female C57BL/6 mice

Dosage form

3 mg/kg daily, i.p.

Application

Administration of the CXCR4 antagonist AMD3100 reduced the uptake of tracer that specifically binding to interleukin-2 receptors expressed on activated CD25+ T cells by 2.8-fold, indicating a CXCR4-dependent infiltration of activated T lymphocytes in cancer treatment.

Other notes

Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal.

References:

[1]. Dong Y, Liu H, Zhang X, et al. Inhibition of SDF-1α/CXCR4 signalling in subchondral bone attenuates post-traumatic osteoarthritis[J]. International Journal of Molecular Sciences, 2016, 17(6): 943.

[2]. Hartimath S V, Draghiciu O, van de Wall S, et al. Noninvasive monitoring of cancer therapy induced activated T cells using [18F] FB-IL-2 PET imaging[J]. OncoImmunology, 2017, 6(1): e1248014.

Quality Control